Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
00241 ALI HEALTH
RT Nominal up7.130 +0.050 (+0.706%)
Ranking Overview
Buy
Ranking based on 14 research report(s)
Average Ranking 2.36
1
9
2
2
0
Previous Financial Performance
Financial Year 03/2021 EPS 2.63 RMB (cts)
Net Profit 348.59 RMB (MIL) DPS 0.00 RMB (cts)
Consolidation Estimation
Financial Year Profit / (Loss)
(RMB (MIL))
EPS/
((LPS)(RMB (cts))
DPS
(RMB (cts))
Net Asset Value per Share
(RMB)
Highest
(RMB (MIL))
Lowest
(RMB (MIL))
2022-429.00-3.000--907.30-653.50
2023-266.30-2.000--1,279.00-727.10
2024303.002.250--1,699.90-425.54
Profit Estimation
Profit Estimation Profit / (Loss)
(RMB (MIL))
EPS*/
(LPS) (RMB (cts))
DPS *
(RMB (cts))
Broker Ranking Target Price*
(HKD)
Update Date
2022689.005.10--SPDB INT'L SECHold21.00 31/05/2021
2022776.006.00--DBS VICKERSBuy19.30 06/09/2021
2022907.307.00--GOLDMAN SACHSBuy17.00 15/09/2021
2022-455.36-3.00--HSBCBuy16.50 24/11/2021
2022-611.00-4.50--BANK OF AMERICABuy15.50 25/11/2021
2022-429.00-3.20--DAI WABuy15.00 25/11/2021
2022-285.00-0.82--CHINA MERCHANTSBuy14.60 26/11/2021
2022635.005.00--CITIC SECADD14.50 19/10/2021
2022-573.98-4.26--MORGAN STANLEYOverweight13.00 26/11/2021
2022-364.70-3.00--CREDIT SUISSEOutPerform11.00 25/11/2021
2022-491.00-4.00--CHINA INT'L CAPITALOutPerform10.90 25/11/2021
2022-480.00-7.00--J.P. MORGANNeutral8.00 29/11/2021
2022-586.00-4.30--BOCISell7.20 17/11/2021
2022-653.50-3.70--UOBSell7.00 25/11/2021
 
20231,071.007.90--SPDB INT'L SEC----31/05/2021
20231,279.0010.00--DBS VICKERS----06/09/2021
20231,194.209.00--GOLDMAN SACHS----15/09/2021
2023-604.85-4.00--HSBC----24/11/2021
2023-667.00-4.90--BANK OF AMERICA----25/11/2021
2023-263.00-2.00--DAI WA----25/11/2021
20231,021.008.00--CITIC SEC----19/10/2021
2023-382.16-2.83--MORGAN STANLEY----26/11/2021
2023-269.60-2.00--CREDIT SUISSE----25/11/2021
2023-359.00-3.00--CHINA INT'L CAPITAL----25/11/2021
2023-219.00-4.00--J.P. MORGAN----29/11/2021
2023-387.00-2.90--BOCI----17/11/2021
2023-727.10-1.80--UOB----25/11/2021
 
20241,562.0011.60--SPDB INT'L SEC----31/05/2021
20241,699.9013.00--GOLDMAN SACHS----15/09/2021
2024-425.54-3.00--HSBC----24/11/2021
2024588.004.40--BANK OF AMERICA----25/11/2021
202418.000.10--DAI WA----25/11/2021
20241,552.0012.00--CITIC SEC----19/10/2021
202411.070.08--MORGAN STANLEY----26/11/2021
2024-121.60-1.00--CREDIT SUISSE----25/11/2021
2024-9.00-0.10--BOCI----17/11/2021
Remarks:  Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa.
  *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue
  Real time quote last updated: 02/12/2021 17:59
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
Profit / (Loss) Attributable to Shareholders (K¥)RMB -231,771
%Change--
EPS / (LPS)RMB -0.017
NBV Per Share (¥)RMB 1.043
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2021 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.